Great Reversal !
Big Pharma is all rushing to develop allogenic CAR-T cells with the exception of four companies that have already commercialised CAR-T cells, but this may end up being a pipe dream. This is because of innovations that have dramatically reduced the culture time for autologous CAR-T cells.
https://miyata-bio.net/column/0000318/
この記事が気に入ったらサポートをしてみませんか？